Christian Herzog

High Impact

Assistant Professor

UAMS

Last publication 2026 Last refreshed 2026-05-16

faculty

Internal Med, College of Medicine

herzogchristian@uams.edu

31 h-index 94 pubs 2,955 cited

Research Areas

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Christian Herzog's research focuses on understanding the molecular mechanisms underlying kidney diseases, particularly membranous nephropathy and acute kidney injury.

His work has identified novel autoantigens and prognostic biomarkers in these conditions. This includes investigating serine protease HTRA1 and TGFBR3-associated proteins as targets in membranous nephropathy, and SOD1 as a biomarker for acute kidney injury following cardiothoracic surgery. Herzog also studies the role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury.

His research group has also explored the immunological responses to SARS-CoV-2 infection, including the development of ACE2 autoantibodies and the induction of anti-idiotype antibodies in transgenic mouse models following vaccination. Herzog holds a h-index of 31 with 94 total publications and 2,923 total citations. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Joseph H. Holthoff, Yanping Izak Harville, Aaron J. Storey, and J. Craig Forrest.

Metrics

h-index: 31
Publications: 94
Citations: 2,955

Selected Publications

Proteomic Profiling of Complement Components in Glomerular Disease (2026)

DOI OpenAlex
The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury (2025)

1 citation DOI OpenAlex
Sequential SARS-CoV-2 mRNA Vaccination Induces Anti-Idiotype (Anti-ACE2) Antibodies in K18 Human ACE2 Transgenic Mice (2025)

3 citations DOI OpenAlex
FSGS in an Adult Transplant Recipient Possibly Linked to a New Antibody against WT1 (2024)

DOI OpenAlex
SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery (2023)

4 citations DOI OpenAlex
Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry (2023)

52 citations DOI OpenAlex
Urine Mass Spectrometry Can Distinguish Prerenal and Intrarenal AKI (2022)

DOI OpenAlex
Minor Antigens in Membranous Nephropathy Identified by Mass Spectrometry (2022)

DOI OpenAlex
Development of ACE2 autoantibodies after SARS-CoV-2 infection (2021)

202 citations DOI OpenAlex
Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy (2021)

57 citations DOI OpenAlex
Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy (2021)

102 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

Pilot: Glomerular biomarkers of progression in IgA nephropathy NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases - Pass Through: University of Pennsylvania Co-Investigator
Meprin A Metalloproteinase in Acute Kidney Injury NIH Co-Investigator
A Device for Detection of Acute Kidney Injury NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases - Pass Through: Nephsmart, LLC Principal Investigator
Factors Associated with Outcomes in Patients on Continuous Dialysis Dialysis Clinic, Inc. Principal Investigator
A Device for Detection of Acute Kidney Injury NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases - Pass Through: Nephsmart, LLC Principal Investigator
Development of a Precision Medicine-Based Diagnostic Tool for Membranous Nephropathy NIH/National Institutes of Health - Pass Through: Arkana Laboratories Principal Investigator